Clinical trial

Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)

NCT03589924

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-06-01

PhaseNA

Study timeline

Study start (actual)2018-06-01Date precision: day

Registry last updated2024-06-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Immediate IBBR+TiLoop®BraPROCEDURE

Immediate-delayed IBBR+TiLoop®BraPROCEDURE

Sponsors & collaborators

Jiong Wulead sponsor

First Hospital of China Medical Universitycollaborator

Second Affiliated Hospital, Zhejiang University, School of Medicinecollaborator

The First Affiliated Hospital with Nanjing Medical Universitycollaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitycollaborator

Mapped research locations

HangzhouZhejiang, China3 GuangzhouGuangdong, China2 ShanghaiShanghai Municipality, China1 NanjingJiangsu, China1 ShenyangLiaoning, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03589924 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.